Cord blood-derived V δ 2 + and V δ 2 - T cells acquire differential cell state compositions upon in vitro expansion

Human cord blood-derived γδ T cells (CB ) display a highly diverse TCR repertoire and have a unique subtype composition different from fetal or adult peripheral blood counterparts. We expanded CB in vitro using an irradiated Epstein-Barr virus-transformed feeder cell-based modified rapid expansion p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2023-06, Vol.9 (24), p.eadf3120
Hauptverfasser: Ng, Jeremy Wee Kiat, Tan, Kar Wai, Guo, Dian Yan, Lai, Joey Jia Hui, Fan, Xiubo, Poon, Zhiyong, Lim, Tse Hui, Lim, Alvin Soon Tiong, Lim, Tony Kiat Hon, Hwang, William Ying Khee, Li, Shang, Eaves, Connie J, Goh, Yeow Tee, Cheung, Alice Man Sze
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Human cord blood-derived γδ T cells (CB ) display a highly diverse TCR repertoire and have a unique subtype composition different from fetal or adult peripheral blood counterparts. We expanded CB in vitro using an irradiated Epstein-Barr virus-transformed feeder cell-based modified rapid expansion protocol (REP). Single-cell RNA sequencing tracked progressive differentiation of naïve CB into cells expressing neoantigen-reactive tumor-infiltrating lymphocyte as well as tissue-resident memory precursor-like and antigen-presenting cell-like gene signatures. TCR clonal tracing revealed a bias toward cytotoxic effector differentiation in a much larger proportion of V 2 clones compared to V 2 clones, resulting in the former being more cytotoxic at the population level. These clonotype-specific differentiation dynamics were not restricted to REP and were recapitulated upon secondary nonviral antigen stimulations. Thus, our data showed intrinsic cellular differences between major subtypes of human γδ T cells already in operation at early postnatal stage and highlighted key areas of consideration in optimizing cell manufacturing processes.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.adf3120